Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Timber Pharmaceuticals, Inc. (TMBR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Dec 2021
Koconis John
CEO & President, Director, Officer
Timber Pharmaceuticals, Inc.
(TMBR)
20,000
+100%
20,000
$0.38
$7,686.00
BUY
23 Nov 2021
Mendelsohn Alan
Chief Medical Officer, Officer
Timber Pharmaceuticals, Inc.
(TMBR)
10,000
+100%
10,000
$0.47
$4,700.00
BUY
23 Nov 2021
Sitar Edward J
Director
Timber Pharmaceuticals, Inc.
(TMBR)
15,000
+100%
15,000
$0.46
$6,900.00
SELL
2 Sep 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
3,508,567
-6%
225,000
$0.94
$210,960.00
SELL
30 Aug 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
3,733,567
-9%
400,500
$0.92
$368,266.34
SELL
24 Aug 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
4,134,067
-6%
300,000
$0.92
$275,630.00
SELL
18 Aug 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
4,434,067
-3%
175,000
$0.96
$168,170.00
SELL
14 Jun 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
4,609,067
-3%
174,915
$1.27
$221,480.31
SELL
8 Jun 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
4,783,982
-10%
587,250
$1.28
$750,215.60
SELL
28 May 2021
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
5,371,232
-1%
66,285
$1.27
$84,019.43
BUY
3 Mar 2021
Mendelsohn Alan
Chief Medical Officer, Officer
Timber Pharmaceuticals, Inc.
(TMBR)
1,988
+100%
1,988
$2.17
$4,313.96
SELL
14 Sep 2020
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
5,437,517
-3%
188,209
$1.03
$193,713.25
SELL
10 Sep 2020
TardiMed Sciences LLC
10% Owner
Timber Pharmaceuticals, Inc.
(TMBR)
5,625,726
-0%
40,426
$1.04
$42,089.05
SELL
10 Feb 2020
Timber Pharmaceuticals LLC
10% Owner
BioPharmX Corp
(BPMX)
2,200,328
-0%
4,584
$0.12
$550.08
SELL
10 Feb 2020
TardiMed Sciences LLC
10% Owner
BioPharmX Corp
(BPMX)
2,200,328
-0%
4,584
$0.12
$550.08
SELL
25 Jun 2019
Vivo Capital VIII, LLC
10% Owner
BioPharmX Corp
(BPMX)
317,270
-7%
27,322.5
$12.24
$334,427.40
SELL
23 Jan 2019
Krammer Anja B
Director
BioPharmX Corp
(BPMX)
1,884,126
-0%
386.247
$33.00
$12,746.14
SELL
18 Oct 2018
Morlock Stephen
Director
BioPharmX Corp
(BPMX)
0
-100%
3,750.09
$55.17
$206,895.86
SELL
10 Oct 2018
Krammer Anja B
Director
BioPharmX Corp
(BPMX)
2,000,000
-0%
1,666.667
$57.00
$95,000.00
BUY
19 Sep 2018
Tierney David S
CEO, Director, Officer
BioPharmX Corp
(BPMX)
7,500,000
+0%
333.333
$60.75
$20,250.00
SELL
7 Mar 2018
Vivo Capital VIII, LLC
10% Owner
BioPharmX Corp
(BPMX)
16,128,515
-0%
6,666.667
$108.00
$720,000.00
BUY
24 Nov 2017
Morlock Stephen
Director
BioPharmX Corp
(bpmx)
873,956
+0%
1,100
$45.00
$49,500.00
SELL
9 Nov 2017
Vivo Capital VIII, LLC
10% Owner
BioPharmX Corp
(BPMX)
13,799,944
-0%
987.98
$60.00
$59,278.80
BUY
1 Aug 2017
FRANKLIN RESOURCES INC
10% Owner
BioPharmX Corp
(BPMX)
9,749,615
+0%
833.333
$101.16
$84,300.00
BUY
28 Apr 2017
Vivo Capital Fund VIII, L.P.
10% Owner
BioPharmX Corp
(BPMX)
14,096,338
+0%
4,273.507
$234.00
$1,000,000.50
BUY
15 Aug 2016
FRANKLIN RESOURCES INC
10% Owner
BioPharmX Corp
(BPMX)
5,124,615
+0%
1,615.383
$195.00
$314,999.75
BUY
29 Mar 2016
FRANKLIN RESOURCES INC
10% Owner
BioPharmX Corp
(BPMX)
4,640,000
+0%
1,800
$360.00
$648,000.00
BUY
13 Jan 2016
Morlock Stephen
Director
BioPharmX Corp
(bpmx)
251,071
+0%
40
$457.38
$18,295.00
BUY
11 Jan 2016
Morlock Stephen
Director
BioPharmX Corp
(bpmx)
239,071
+0%
20
$459.00
$9,180.00
BUY
7 Jan 2016
Morlock Stephen
Director
BioPharmX Corp
(BPMX)
233,071
+0%
16.667
$441.00
$7,350.00
Home